neoLaser

neoLaser is an Israeli medical device company focused on the design, manufacture, and commercialization of medical and surgical laser systems. The company markets the neoV family of laser platforms and related fibers, probes, kits, and accessories for endovenous laser ablation, proctology, PLDD/spine, and selected aesthetic, podiatry, dental, and soft-tissue surgical applications. Its technology emphasizes compact diode-based laser systems, proprietary fiber delivery tools, and minimally invasive procedural workflows, including the CORONA fiber line for vein and anorectal indications. neoLaser appears to be a commercial-stage healthcare company rather than a therapeutics developer, with products sold internationally and regulatory clearances including CE-marked offerings and FDA-cleared products. In July 2024, neoLaser became part of the newly formed MedTech Laser Group in a majority-stake transaction led by Afinum, while founders reinvested into the group.